BioNTech Names Guido Oelkers as Future Chief Executive
German biotechnology company BioNTech has appointed pharmaceutical executive Guido Oelkers to become chief executive next year, succeeding founder Uğur Şahin as the company shifts its focus toward advancing personalized cancer therapies after the pandemic era.